Boyer, C.M., Y. Lidor, S.C. Lottich and R.C. Bast, Jr.1988. "Antigenic Cell Surface Markers in Human Solid Tumors ," Antibody, Immunoconjugates, and Radiopharmaceuticals, 1:105-162.
2.
Sell, S.1990. "Cancer Markers of the 1990s. Comparison of the New Generation of Markers Defined by Monoclonal Antibodies and Oncogene Probes to Prototypic Markers," Clin. Lab. Med., 10:1-37.
3.
Blair, A.H. and T.I. Ghose.1983. "Linkage of Cytotoxic Agents to Immunoglobulins ," J. Immunol. Methods, 59:129-143.
4.
Hara, T. and Y. Kato.1988. "Antibody-Cytotoxic Agent Conjugates for Cancer Targeting Therapy," J. Synth. Org Chem. (Tokyo) , 46:1106-1115.
5.
Pimm, M.V.1988. "Drug-Monoclonal Antibody Conjugates for Cancer Therapy: Potentials and Limitations," Crit. Rev. Ther. Drug Carrier Syst., 5:189-227.
6.
Koppel, G.A.1990. "Recent Advances with Monoclonal Antibody Drug Targeting for the Treatment of Human Cancer," Bioconjugate Chem., 1:13-23.
7.
Smyth, M.J., G.A. Pietersz, B.J. Classon and I.F.C. McKenzie .1986. "Specific Targeting of Chlorambucil to Tumors with the Use of Monoclonal Antibodies," Int. Natl. J. Cancer, 76:503-510.
8.
Biddle, W.C., Y. Haruta, B.K. Seon, E.S. Henderson and E.J. Sarcione.1989. "In Vitro and In Vivo Cytotoxic Activity of Anti-Human Leukemia Monoclonal Antibodies SN5c and SN6 Daunorubicin Conjugates ," Leukemia Res., 13:699-707.
9.
Aboud-Pirak, E., E. Hurwitz, F. Bellot, J. Schlessinger and M. Sela.1989. " Inhibition of Human Tumor Growth in Nude Mice by a Conjugate of Doxorubicin with Monoclonal Antibodies to Epidermal Growth Factor Receptor," Proc. Natl. Acad. Sci. U.S.A., 86:3778-3781.
10.
Umemoto, N. , Y. Kato, Y. Takeda, M. Saito, T. Hara, M. Seto and T. Takahashi.1984. "Conjugates of Mitomycin C with the Immunoglobulin M Monomer Fragment of a Monoclonal Anti-MM46 Immunoglobulin M Antibody with or without Serum Albumin as Intermediary," J. Appl. Biochem., 6:297-307.
11.
Hashimoto, Y., M. Sugawara, T. Masuko and H. Hojo.1983. "Antitumor Effect of Actinomycin D Entrapped in Liposomes Bearing Subunits of Tumor-Specific Monoclonal Immunoglobulin M Antibody," Cancer Res., 43:5328-5334.
12.
Luders, G., W. Kohnlein, C. Sorg and J. Bruggen.1985. "Selective Toxicity of Neocarzinostatin-Monoclonal Antibody Conjugates to the Antigen-Bearing Human Melanoma Cell Line In Vitro," Cancer Immunol. Immunother., 20:85-90.
13.
Aboud-Pirak, E., B. Lesur, K.S.P.B. Rao, R. Baurain, A. Trouet and Y.-J. Schneider.1989. "Cytotoxic Activity of Daunorubicin or Vindesin Conjugated to a Monoclonal Antibody on Cultured MCF-7 Breast Carcinoma Cells," Biochem. Pharmacol., 38:641-648.
14.
Johnson, I.S. , M.E. Spearman, G.C. Todd, J.L. Zimmerman and T.F. Bumol.1987. " Monoclonal Antibody Drug Conjugates for Site-Directed Cancer Chemotherapy: Preclinical Pharmacology and Toxicology Studies," Cancer Treatment Rev., 14:193-196.
15.
Embleton, M.J. and M.C. Garnett.1985. "Antibody Targeting of AntiCancer Agents," in Monoclonal Antibodies for Cancer Detection and Therapy, R. W Baldwin and V. S. Byers, eds., London : Academic Press Inc., pp. 317-344.
16.
Nalpern, S.E. , P.L. Hagan, P.R. Garver, J.A. Koziol, A.W.N. Chen, J.M. Frincke, R.M. Bartholomew, G.S. David and T.H. Adams.1983. "Stability, Characterization, and Kinetics of 111In-Labeled Monoclonal Antitumor Antibodies in Normal Animals and Nude Mouse-Human Tumor Models," Cancer Res., 43:5347-5355.
17.
Huennekens, F.M., T.H. Duffy, L.E. Pope, G.C. Grundler, J.K. Sato and K.S. Vitols.1987. "Biochemistry of Methotrexate: Teaching an Old Drug New Tricks," in Cancer Biology and Therapeutics , J. G. Cory and A. Szentivanyi, eds., NY: Plenum Publishing Co., pp. 43-61.
18.
Trouet, A., D. Deprez-De Campeneere and C. De-Duve.1972. "Chemotherapy through Lysosomes with a DNA-Daunorubicin Complex," Nature (London) New Biol ., 239:110-112.
19.
Mathe, G., T.B. Loc and J. Bernard.1958. "Effect sur la leucemie 1210 de la souris d'une combinaison par diazotation d'A-methopterine et de γ-globulines de hamsters porteurs de cette leucemie par heterogreffe," C. R. Acad. Sci., 246:1626-1628.
20.
DeCarvalho, S., H.J. Rand and A. Lewis.1964. "Coupling of Cyclic Chemotherapeutic Compounds to Immune Gamma-Globulins," Nature , 202:255-258.
21.
Calendi, E. , G. Costanzi, F. Indiveri, G. Lotti and C. Zini.1969. "Histoimmunologic Specificity of an Anti-Limphoid Tissue Sarcoma γ-Globulin Bound to Methotrexate," Boll. Chim. Farm., 108:25-28.
22.
Robinson, D.A. , J.M. Whiteley and N.G.L. Harding.1973. " Cell-Directed Antimetabolites: Alternative Syntheses of Cytotoxic Methotrexate-Containing Macromolecules," Biochemical Society Transactions, 1:722-726.
23.
Elias, D.J. , L. Hirschowitz, L.E. Kline, J.F. Kroener, R.O. Dillman, L.E. Walker, J.A. Robb and R.M. Timms.1990. "Phase I Clinical Comparative Study of Monoclonal Antibody KS1/4 and KS1/4-Methotrexate Immunoconjugate in Patients with Non-Small Cell Lung Carcinoma," Cancer Res. , 50:4154-4159.
24.
Burstein, S.1977. "Chemotherapy of Murine Ovarian Carcinoma by Methotrexate-Antibody Conjugates," J. Med. Chem. , 20:950-952.
25.
Latif, Z.A. , B.B. Lozzio, C.J. Wust, S. Krauss, M.C. Aggio and C.B. Lozzio.1980. "Evaluation of Drug-Antibody Conjugates in the Treatment of Human Myelosarcomas Transplanted in Nude Mice ," Cancer, 45:1326-1333.
26.
Kulkarni, P.N. , A.H. Blair and T.I. Ghose.1981. "Covalent Binding of Methotrexate to Immunoglobulins and the Effect of Antibody-Linked Drug on Tumor Growth In Vivo," Cancer Res., 41:2700-2706.
27.
Ghosh, M.K. , D.O. Kildsig and A.K. Mitra.1989. "Preparation and Characterization of Methotrexate-Immunoglobulin Conjugates," Drug Design and Delivery, 4:13-25.
28.
Vadia, P., A.H. Blair and T. Ghose.1983. "Uptake of Methotrexate Linked to an Anti-EL4-Lymphoma Antibody by EL4 Cells," Cancer Immunol. Immunother., 16:127-129.
29.
Vadia, P., A.H. Blair and T. Ghose.1984. "Tumor and Tissue Distribution of a Methotrexate-Anti-EL4 Immunoglobulin Conjugate in EL4 Lymphoma-Bearing Mice ," Cancer Res., 44:4263-4266.
30.
Kulkarni, P.N. , A.H. Blair, T. Ghose and M. Mammen.1985. "Conjugation of Methotrexate to IgG Antibodies and Their F(ab')2 Fragments and the Effect of Conjugated Methotrexate on Tumor Growth In Vivo," Cancer Immunol. Immunother., 19:211-214.
31.
Vadia, P., A.H. Blair, T. Ghose and S. Ferrone.1985. "Uptake of Methotrexate Linked to Polyclonal and Monoclonal Antimelanoma Antibodies by a Human Melanoma Cell Line," J. Natl. Cancer Inst., 74:29-35.
32.
Kannelos, J., G.A. Pietersz and I.F.C. McKenzie .1985. "Studies of Methotrexate-Monoclonal Antibody Conjugates for Immunotherapy," J. Natl. Cancer Inst. , 75:319-332.
33.
Smyth, M.J. , G.A. Pietersz and I.F.C. McKenzie.1987. " The Mode of Action of Methotrexate-Monoclonal Antibody Conjugates," Immunol. Cell Biol., 65:(Pt. 2), 189-200.
34.
Kanellos, J. , G.A. Pietersz, Z. Cunningham and I.F.C. McKenzie.1987. " Anti-Tumour Activity of Aminopterin-Monoclonal Antibody Conjugates; In Vitro and In Vivo Comparison with Methotrexate-Monoclonal Antibody Conjugates," Immunol. Cell Biol., 65:(Pt. 6), 483-493.
35.
Pietersz, G.A. , M.J. Smyth, J. Kenellos, Z. Cunningham, N.P.M. Sacks and I.F.C. McKenzie.1988. "Preclinical and Clinical Studies with a Variety of Immunoconjugates ," Antibody, Immunoconjugates, and Radiopharmaceuticals, 1:79-103.
36.
Durrant, L.G. , M.C. Garnett, J. Gallego, N.C. Armitage, K.C. Ballantyne, P.A. Marksman, J.D. Hardcastle and R.W. Baldwin.1987. " Sensitivity of Newly Established Colorectal Cell Lines to Cytotoxic Drugs and Monoclonal Antibody Drug Conjugates," Br. J. Cancer, 56:722-726.
37.
Pimm, M.V., J.A. Clegg, M.C. Garnett and R.W. Baldwin.1988. "Biodistribution and Tumor Localization of a Methotrexate-Monoclonal-Antibody 791T/36 Conjugate in Nude Mice with Human Tumor Xenografts," Int. J. Cancer, 41:886-891.
38.
Ballantyne, K.C., A.C. Perkins, M.V. Pimm, M.C. Garnett, J.A. Clegg, N.C. Armitage, R.W. Baldwin and J.D. Hardcastle.1988. "Biodistribution of a Monoclonal Antibody-Methotrexate Conjugate (791T/36-MTX) in Patients with Colorectal Cancer," Int. J. Cancer (Suppl.2):103-108.
39.
Shawler, D.L. , D.E. Johnson, M.D. Sweet, L.J. Myers, S.D. Tudor, D.E. Beidler, J.A. Koziol and R.O. Dillman.1988. "Preclinical Trials Using an Immunoconjugate of T101 and Methotrexate in an Athymic Mouse/Human T-Cell Tumor Model," J. Biol. Response Modifiers, 7:608-618.
40.
Dillman, P.O. , D.E. Johnson, J. Ogden and D. Beidler.1989. "Significance of Antigen, Drug, and Tumor Cell Targets in the Preclinical Evaluation of Doxorubicin, Daunorubicin, Methotrexate, and Mitomycin-C Monoclonal Antibody Immunoconjugates ," Mol. Biother., 1:250-255.
41.
Deguchi, T. , T.M. Chu, S.S. Leong, J.S. Horoszewicz and C.-I. Lee.1986. " Effect of Methotrexate-Monoclonal Anti-Prostatic Acid Phosphatase Antibody Conjugate on Human Prostate Tumor," Cancer Res., 46:3751-3755.
42.
Rowland, A.J. , M.E. Harper, D.W. Wilson and K. Griffiths.1990. "The Effect of an Anti-Membrane Antibody-Methotrexate Conjugate on the Human Prostatic Tumor Line PC3," Br. J. Cancer, 61:702-708.
43.
Endo, N., Y. Takeda, K. Kishida, Y. Kato, M. Saito, N. Umemoto and T. Hara.1987. "Target-Selective Cytotoxicity of Methotrexate Conjugated with Monoclonal Anti-MM46 Antibody," Cancer Immunol. Immunother., 25:1-6.
44.
Endo, N., Y. Takeda, N. Umemoto, K. Kishida, K. Watanabe, M. Saito, Y. Kato and T. Hara.1988. "Nature of Linkage and Mode of Action of Methotrexate Conjugated with Antitumor Antibodies: Implications for Future Preparation of Conjugates," Cancer Res., 48:3330-3335.
45.
Kralovec, J. , G. Spencer, A.H. Blair, M. Mammen, M. Singh and T. Ghose.1989. "Synthesis of Methotrexate-Antibody Conjugates by Regiospecific Coupling and Assessment of Drug and Antitumor Activities," J. Med. Chem., 32:2426-2431.
46.
Piper, J.R. , J.A. Montgomery, F.M. Sirotnak and P.L. Chello.1982. "Syntheses of α- and γ-Substituted Amides, Peptides, and Esters of Methotrexate and Their Evaluation as Inhibitors of Folate Metabolism," J. Med. Chem. , 25:182-187.
47.
Baldwin, R.W. , M.J. Embleton, M.C. Garnett and M.V. Pimm.1987. "Conjugates of Monoclonal Antibody 791T/36 with Methotrexate in Cancer Therapy," NCI Monogr., 3:95-99.
48.
Raso, V., C. Fehrmann, V.C. Solan and A. Rosowsky.1988. "Monensin is Obligatory for the Cytotoxic Action of a Disulfide Linked Methotrexate-Anti-Transferrin Receptor Conjugate ," Biochem. Biophys. Res. Commun., 150:104-110.
49.
Umemoto, N. , Y. Kato and T. Hara.1989. "Cytotoxicities of Two Disulfide-Bond-Linked Conjugates of Methotrexate with Monoclonal Anti-MM46 Antibody," Cancer Immunol. Immunother., 28:9-16.
50.
Umemoto, N. , Y. Kato, N. Endo, Y. Takeda and T. Hara.1989. "Preparation and In Vitro Cytotoxicity of a Methotrexate-Anti-MM46 Monoclonal Antibody Conjugate via an Oligopeptide Spacer," Int. J. Cancer, 43:677-684.
51.
Masuho, Y. and T. Hara.1980. "Target-Cell Cytotoxicity of a Hybrid of Fab' of Immunoglobulin and A-Chain of Ricin," Gann (Jpn. J. Cancer Res.), 71:759-765.
52.
Trouet, A., M. Masquelier, R. Baurain and D. Deprez-DeCampeneere .1982. "A Covalent Linkage between Daunorubicin and Proteins that is Stable in Serum and Reversible by Lysosomal Hydrolases, as Required for a Lisosomotropic Drug-Carrier Conjugate: In Vitro and In Vivo Studies," Proc. Natl. Acad. Sci. U.S.A., 79:626-629.
53.
Lesur, B., M. Masquelier, R. Baurain, Y.-J. Schneider and A. Trouet.1984. "Covalent Linkage of Anthracyclines to Macromolecular Carriers," Protides Biol. Fluids, 32:437-440.
54.
Endo, N., N. Umemoto, Y. Kato, Y. Takeda and T. Hara.1987. "A Novel Covalent Modification of Antibodies at Their Amino Groups with Retention of Antigen-Binding Activity," J. Immunol. Methods, 104:253-258.
55.
Lopes, A.D., R.D. Radcliffe, D.J. Coughlin, L.S. Lee, T.J. McKearn and J.D. Rodwell.1987. "Site-Selective Methotrexate-Antibody Conjugates Yield a Superior Therapeutic Effect in Tumor Xenograft-Bearing Nude Mice," in Clinical Immunology, W Pruzanski and M. Seligmann, eds., New York: Elsevier, pp. 303-307.
56.
Kralovec, J. , M. Singh, M. Mammen, A.H. Blair and T. Ghose.1989. "Synthesis of Site-Specific Methotrexate-IgG Conjugates. Comparison of Stability and Antitumor Activity with Active-Ester-Based Conjugates," Cancer Immunol. Immunother. , 29:293-302.
57.
Shih, L.B., R.M. Sharkey, F.J. Primus and D.M. Goldenberg .1988. "Site-Specific Linkage of Methotrexate to Monoclonal Antibodies Using an Intermediate Carrier," Int. J. Cancer, 41:832-839.
58.
Montgomery, J.A. and J.R. Piper.1984. "Design and Synthesis of Folate Analogs as Antimetabolites," in Folate Antagonists as Therapeutic Agents, Vol. 1, F. M. Sirotnak, J. J. Burchall , W. B. Ensminger and J. A. Montgomery, eds., Orlando: Academic Press Inc., pp. 219-260.
59.
Garnett, M.C. , M.J. Embleton, E. Jacobs and R.W. Baldwin.1983. "Preparation and Properties of a Drug-Carrier-Antibody Conjugate Showing Selective Antibody-Directed Cytotoxicity In Vitro," Int. J. Cancer, 31:661-670.
60.
Garnett, M.C. , E. Jacobs, M.J. Embleton and R.W. Baldwin.1984. "Studies on the Mechanism of Action of a Drug-Carrier-Antibody Conjugate," Biochemical Society Transactions, 12:1035-1036.
61.
Baldwin, R.W. , M.J. Embleton, M.C. Garnett, M.V. Pimm, M.R. Price, N.A. Armitage, P.A. Farrands, J.D. Hardcastle, A. Perkins and G.F. Rowland.1984. "Application of Monoclonal Antibody 791T/36 for Radioimmunodetection of Human Tumours and for Targeting Cytotoxic Drugs," Protides Biol. Fluids, 31:775-781.
62.
Embleton, M.J. , M.C. Garnett, E. Jacobs and R.W. Baldwin.1984. "Antigenicity and Drug Susceptibility of Human Osteogenic Sarcoma Cells "Escaping" a Cytotoxic Methotrexate-Albumin-Monoclonal Antibody Conjugate," Br. J. Cancer, 49:559-565.
63.
Garnett, M.C. , M.J. Embleton, E. Jacobs and R.W. Baldwin.1985. "Studies on the Mechanism of Action of an Antibody-Targeted Drug-Carrier Conjugate," Anti-Cancer Drug Design, 1:3-12.
64.
Embleton, M.J. , M.C. Garnett and R.W. Baldwin.1985. "Use of an Anti-Tumour Monoclonal Antibody for Targeting Methotrexate," Protides Biol. Fluids, 32:429-431.
65.
Garnett, M.C. and R.W. Baldwin.1986. "An Improved Synthesis of a Methotrexate-Albumin-791T/36 Monoclonal Antibody Conjugate Cytotoxic to Human Osteogenic Sarcoma Cell Lines," Cancer Res., 46:2407-2412.
66.
Affleck, K. and M.J. Embleton.1989. "Sensitivity of a Methotrexate-Resistant-Tumour Cell Line to a Methotrexate-Albumin-Monoclonal Antibody Conjugate," Br. J. Cancer, 60:474-475.
67.
Embleton, M.J. , N.A. Habib, M.C. Garnett and C. Wood.1986. "Unsuitability of Monoclonal Antibodies to Oncogene Proteins for Anti-Tumour Drug-Targeting," Int. J. Cancer, 38:821-827.
68.
Endo, N., Y. Kato, Y. Takeda, M. Saito, N. Umemoto, K. Kishida and T. Hara.1987. "In Vitro Cytotoxicity of a Human Serum Albumin-Mediated Conjugate of Methotrexate with Anti-MM46 Monoclonal Antibody ," Cancer Res., 47:1076-1080.
69.
Pietersz, G.A. , Z. Cunningham and I.F.C. McKenzie.1988. " Specific In Vitro Anti-Tumour Activity of Methotrexate-Monoclonal Antibody Conjugates Prepared Using Human Serum Albumin as an Intermediary," Immunol. Cell Biol., 66:(Pt. 1), 43-49.
70.
Pimm, M.V., R.A. Robins, M.J. Embleton, E. Jacobs, A.J. Markham, A. Charleston and R.W. Baldwin.1990. "A Bispecific Monoclonal Antibody against Methotrexate and a Human Tumor Associated Antigen Augments Cytotoxicity of Methotrexate-Carrier Conjugate," Br. J. Cancer, 61: 508-513.
71.
Shen, W.-C. , B. Ballou, H.J.-P. Ryser and T.R. Hakala.1986. "Targeting, Internalization, and Cytotoxicity of Methotrexate-Monoclonal Anti-Stage-Specific Embryonic Antigen-1 Antibody Conjugates in Cultured F-9 Teratocarcinoma Cells," Cancer Res., 46:3912-3916.
72.
Persiani, S. , B. Ballou, W.-C. Shen, H.J.-P. Ryser, J.M. Reiland and T.R. Hakala.1989. "In Vitro Antitumor Effect of Methotrexate Conjugated to a Monoclonal IgM Antibody Specific for Stage-Specific Embryonic Antigen-1, on MH-15 Mouse Teratocarcinoma," Cancer Immunol. Immunother., 29:167-170.
